Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01846741 · ClinicalTrials.gov registry record · NA

VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)

A NA study of Epilepsy, sponsored by Cyberonics.

Completed
Registry status
NA
Development phase
20
Enrollment target
15
Study locations

NCT01846741 is a NA study of Epilepsy that has completed, run by Cyberonics. The registered enrollment target is 20 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower). The trial reports 15 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01846741, a NA study of Epilepsy, has completed, sponsored by Cyberonics.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
15
Study locations

Study Summary

Obtain baseline clinical outcome data (Stage 1) upon which to base a subsequent study (Stage 2) of the Model 106 VNS implantable pulse generator

Conditions Studied

Epilepsy

Interventions

  • DEVICE M106 VNS Therapy System

Study Locations (15)

Texas

  • - Dallas
  • - Houston

Arizona

  • - Phoenix

California

  • - Stanford

Florida

  • - Tampa

Georgia

  • - Atlanta

Illinois

  • - Chicago

Michigan

  • - Ann Arbor

Minnesota

  • - Saint Paul

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-07
Est. Completion 2015-08
Phase NA

Sponsor

Cyberonics

15 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01846741

The ClinicalTrials.gov registry entry for NCT01846741 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (98% lower). The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which M106 VNS Therapy System is the first listed.

NCT01846741 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Texas, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT01846741 about?

NCT01846741 is a clinical study titled "VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)". Obtain baseline clinical outcome data (Stage 1) upon which to base a subsequent study (Stage 2) of the Model 106 VNS implantable pulse generator

What is the current status of trial NCT01846741?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-07. Estimated completion is 2015-08.

What conditions does trial NCT01846741 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT01846741?

The interventions under investigation include: M106 VNS Therapy System (DEVICE).

Who is sponsoring clinical trial NCT01846741?

This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01846741 being conducted?

This trial has 15 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.